Medicare Enrolled

Dr. Todd Panarese, M.D.

Radiology - Diagnostic · Merritt Island, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
215 CONE RD, Merritt Island, FL 32952
3214537440
In practice since 2006 (19 years)
NPI: 1427125053 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Panarese from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Panarese? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Panarese

Dr. Todd Panarese is a radiology - diagnostic in Merritt Island, FL, with 19 years in practice. Based on federal Medicare data, Dr. Panarese performed 9,577 Medicare services across 1,806 unique beneficiaries.

Between the years covered by Open Payments, Dr. Panarese received a total of $9,724 from 66 pharmaceutical and/or device companies across 200 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiology - diagnostic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Panarese is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 8% volume in FL$ $9,724 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,577
Medicare services
Top 8% in FL for radiology - diagnostic
1,806
Unique beneficiaries
$126
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~504 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Contrast dye for imaging (iodine-based)2,055$0$3
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy1,914$58$637
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session1,628$275$2,582
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev1,001$179$529
Radiation treatment management, 5 treatment sessions475$155$1,036
Continuing radiation therapy consultation per week470$67$333
Office visit, established patient (20-29 min)304$62$180
Calculation of radiation therapy dose260$52$354
CT guidance for radiation therapy258$94$595
Leuprolide acetate (for depot suspension), 7.5 mg235$131$3,938
Design and construction of complex radiation treatment device118$97$689
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle81$24$141
Complex radiation therapy planning77$134$992
Special radiation therapy planning73$51$269
Tissue marker, implantable, any type, each60$74$2,000
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area57$208$631
New patient office visit, complex (60-74 min)50$168$432
High precision radiation therapy planning49$1,426$6,820
Design and construction of radiation treatment device for high precision radiation therapy49$365$2,563
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries47$410$1,370
Nuclear medicine study from skull base to mid-thigh with ct scan42$1,211$4,120
Cranial lesion surgery using radiation over multiple sessions39$770$7,971
New patient office visit (45-59 min)38$127$420
Office visit, established patient (30-39 min)38$94$224
Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved27$345$1,165
Ct scan of chest with contrast25$104$1,005
Special radiation treatment21$111$1,741
3d radiation therapy planning15$364$4,247
New patient office visit (30-44 min)15$78$230
Placement of device in prostate for radiation therapy14$121$454
CT scan of abdomen and pelvis with contrast14$248$1,400
Ultrasound scan of pelvic region through rectum14$106$418
Ultrasonic guidance for needle placement14$46$615
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
74.2% medium
25.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,724
Total received (2018-2024)
Avg $1,389/year across 7 years
Top 12% in FL for radiology - diagnostic
66
Companies
200
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,724 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,791
2023
$1,329
2022
$763
2021
$1,495
2020
$581
2019
$1,479
2018
$2,286

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$939
Merck Sharp & Dohme LLC
$462
Genentech USA, Inc.
$453
E.R. Squibb & Sons, L.L.C.
$437
Novartis Pharmaceuticals Corporation
$417
Incyte Corporation
$379
Ipsen Biopharmaceuticals, Inc
$372
Janssen Biotech, Inc.
$345
Takeda Pharmaceuticals U.S.A., Inc.
$325
Eisai Inc.
$324
Seagen Inc.
$299
Amgen Inc.
$285
Regeneron Healthcare Solutions, Inc.
$272
Exelixis Inc.
$247
EISAI INC.
$202
Janssen Scientific Affairs, LLC
$170
Mirati Therapeutics, Inc.
$163
TAIHO ONCOLOGY, INC.
$153
Celgene Corporation
$142
JAZZ PHARMACEUTICALS INC.
$141
Astellas Pharma US Inc
$140
Pharmacyclics LLC, An AbbVie Company
$140
Bayer HealthCare Pharmaceuticals Inc.
$138
Blueprint Medicines Corporation
$135
BeiGene USA, Inc.
$133
GENZYME CORPORATION
$131
Novocure Inc.
$129
ABBVIE INC.
$125
Epizyme, Inc.,
$125
EUSA Pharma (US) LLC
$125
EMD Serono, Inc.
$124
Taiho Oncology, Inc.
$120
Helsinn Therapeutics (U.S.), Inc.
$118
Myovant Sciences Inc.
$115
Teleflex LLC
$112
Aveo Pharmaceuticals, Inc.
$109
Boehringer Ingelheim Pharmaceuticals, Inc.
$101
SERVIER PHARMACEUTICALS LLC
$94
Augmenix, Inc.
$89
Daiichi Sankyo Inc.
$88
TerSera Therapeutics LLC
$83
Pharmacyclics LLC, an AbbVie Company
$76
Pharmacosmos Therapeutics Inc.
$68
Dendreon Pharmaceuticals LLC
$57
SOBI, INC
$53
Gilead Sciences, Inc.
$50
Lilly USA, LLC
$40
ARRAY BIOPHARMA INC
$38
GlaxoSmithKline, LLC.
$30
G1 Therapeutics, Inc.
$29
Apellis Pharmaceuticals, Inc.
$25
TOLMAR Pharmaceuticals, Inc.
$22
Alexion Pharmaceuticals, Inc.
$22
INSYS Therapeutics Inc
$20
Deciphera Pharmaceuticals Inc.
$19
PFIZER INC.
$18
Bayer Healthcare Pharmaceuticals Inc.
$18
Sumitomo Pharma America, Inc.
$18
Biocon Biologics Inc
$17
Amneal Pharmaceuticals LLC
$17
PUMA BIOTECHNOLOGY, INC.
$16
West Therapeutics Development, LLC
$16
Midatech Pharma US Inc
$15
Seattle Genetics, Inc.
$15
Fortovia Therapeutics, Inc.
$15
Heron Therapeutics, Inc.
$8
Top 3 companies account for 19.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ASPARLAS · AVASTIN · Alecensa · Avastin · BRUKINSA · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELAHERE · ELIGARD · ENHERTU · EPKINLY · Empaveli · Enhertu · Erleada · FOTIVDA · GAVRETO · GILOTRIF · Gelclair · IDHIFA · IMBRUVICA · IMFINZI · INREBIC · Imbruvica · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · OPDIVO · ORGOVYX · Ogivri · Oncology · Onivyde · Optune · PADCEV · PEMAZYRE · PLUVICTO · PROVENGE · Perjeta · Prolia · QINLOCK · RYBREVANT · Revlimid · Rituxan · SOMATULINE DEPOT · SUBSYS · SUSTOL · Somatuline Depot · SpaceOAR · Stivarga · Subsys · Sylvant · TAGRISSO · TAZVERIK · TUKYSA · Tazverik · ULTOMIRIS · VENCLEXTA · VONJO · VONVENDI · Vectibix · Venclexta · XGEVA · XOSPATA · XTANDI · Xtandi · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $102 per 100 Medicare services performed
Looking for a radiology - diagnostic in Merritt Island?
Compare radiology - diagnostics in the Merritt Island area by procedure volume, costs, and industry payment transparency.
Browse radiology - diagnostics nearby

Geographic Context

Radiology - Diagnostics within 10 mi
11
Per 100K population
1.8
County median income
$75,817
Nearest hospital
CAPE CANAVERAL HOSPITAL
2.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Panarese is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), and high industry engagement (low-engagement, top 12%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Panarese experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Panarese performed 2,055 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Panarese receive payments from pharmaceutical companies?
Yes. Dr. Panarese received a total of $9,724 from 66 companies across 200 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Panarese's costs compare to other radiology - diagnostics in Merritt Island?
Dr. Panarese's average Medicare payment per service is $126. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Panarese) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →